Sputum Desmosine During Hospital Admission for Pulmonary Exacerbation in Cystic Fibrosis

BACKGROUND: Cystic fibrosis (CF) lung disease is characterized by structural changes in the airways and parenchyma. No sputum biomarker exists to measure the degree of active structural destruction during pulmonary exacerbation in patients with CF. The noninvasive measurement of desmosine, a breakdo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Laguna, Theresa A., Wagner, Brandie D., Luckey, Heidi K., Mann, Shelley A., Sagel, Scott D., Regelmann, Warren, Accurso, Frank J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American College of Chest Physicians 2009
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2789924/
https://ncbi.nlm.nih.gov/pubmed/19567495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.09-0217
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi